Zymeworks ZYME Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$102.66M-26.5% | -$81.13M-27.9% | -$63.43M+13.9% | -$73.68M+35.2% | -$113.68M+7.3% | ||
| $3.65M-0.5% | $3.67M-2.6% | $3.77M-3.3% | $3.9M-5.1% | $4.11M-1.9% | ||
| $28.57M+1.9% | $28.03M+15.8% | $24.21M+10.2% | $21.96M+6.4% | $20.64M+16.0% | ||
| $845K+189% | -$945K-42.7% | -$662K-5.4% | -$628K-96.9% | -$319K+53.8% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | -$14.45M— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$21.42M+7.6% | -$23.17M— | —— | —— | —— | ||
| -$60K-33.3% | -$45K+95.7% | -$1.06M+42.4% | -$1.83M-5.8% | -$1.73M-3.0% | ||
| $2.62M-35.5% | $4.06M-30.9% | $5.87M-5.4% | $6.21M+14.7% | $5.41M+20.4% | ||
| $4.39M+29.6% | $3.39M+7.4% | $3.15M+13.8% | $2.77M+3.8% | $2.67M+6.3% | ||
| -$75.32M-128% | -$33.01M+48.6% | -$64.26M-65.9% | -$38.72M+48.9% | -$75.79M+31.1% | ||
| $1.72M+13.1% | $1.52M+21.3% | $1.25M-28.1% | $1.74M-4.3% | $1.82M-8.5% | ||
| $509K-38.7% | $831K+20.1% | $692K-13.0% | $795K-14.3% | $928K-13.7% | ||
| $84.44M+217% | $26.66M— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $7.95M— | $0-100% | $10.08M+367% | $2.16M+322% | -$971K— | ||
| $158.91M+956% | -$18.56M-119% | -$8.46M+59.7% | -$20.98M+1.3% | -$21.25M-4.0% | ||
| —— | —— | —— | $35K-81.1% | $185K-37.1% | ||
| $168.08M+774% | -$24.95M+56.6% | -$57.52M— | —— | —— | ||
| $1.21M-10.5% | $1.35M-67.9% | $4.21M+15.2% | $3.66M+2.5% | $3.57M+12.2% | ||
| —— | —— | —— | —— | —— | ||
| $2.62M-35.5% | $4.06M-30.9% | $5.87M-5.4% | $6.21M+14.7% | $5.41M+20.4% | ||
| $3.65M-0.5% | $3.67M-2.6% | $3.77M-3.3% | $3.9M-5.1% | $4.11M-1.9% | ||
| —— | —— | —— | $215K-81.5% | $1.16M-28.1% | ||
| $845K+189% | -$945K-42.7% | -$662K-5.4% | -$628K-96.9% | -$319K+53.8% | ||
| -$3.53M-5.7% | -$3.34M-1.7% | -$3.29M-4.5% | -$3.15M+61.1% | -$8.09M+2.7% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $4.39M+29.6% | $3.39M+7.4% | $3.15M+13.8% | $2.77M+3.8% | $2.67M+6.3% | ||
| $509K-38.7% | $831K+20.1% | $692K-13.0% | $795K-14.3% | $928K-13.7% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $24.85M+47.0% | $16.9M+55.6% | $10.86M+33.5% | $8.14M+3.2% | $7.89M-11.0% | ||
| —— | —— | —— | —— | —— | ||
| $1.68M-31.3% | $2.44M0.0% | $2.44M+46.5% | $1.67M+18.4% | $1.41M+119% | ||
| $1.21M-10.5% | $1.35M-67.9% | $4.21M+15.2% | $3.66M+2.5% | $3.57M+12.2% | ||
| -$77.04M-123% | -$34.53M+47.3% | -$65.51M-61.9% | -$40.47M+47.9% | -$77.61M+30.7% | ||
| -$77.04M-123% | -$34.53M+47.3% | -$65.51M-61.9% | -$40.47M+47.9% | -$77.61M+30.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Zymeworks generate?
- Zymeworks (ZYME) generated -$75.3M in operating cash flow over the trailing twelve months.
- What is Zymeworks's free cash flow?
- After $1.7M of capital expenditures, Zymeworks's free cash flow was -$77.0M over the trailing twelve months, up 0.7% year over year.
- Where does Zymeworks's cash flow data come from?
- Every line is extracted from Zymeworks's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
